Leerink Partners Raises Price Target on Agilent Technologies (A) to $51 Following 2Q

Pre-Open Stock Movers 05/17: (MGT) (NQ) (A) (P) Higher; (FRAN) (AEGR) (LC) Lower (more...)

Today's Pre-Open Stock Movers:

Francescas Holdings Corporation (NASDAQ: FRAN) 26.9% LOWER; announced that its Chairman, President and CEO, Michael W. Barnes, resigned. Updated guidance

MGT Capital Investments, Inc. (NYSE: MGT)... More

Jefferies Raises Price Target on Agilent Technologies (A) Following 2Q Beat and Raise

Jefferies reiterated a Buy rating on Agilent Technologies (NYSE: A), and raised the price target to $51.00 (from $46.00), following the company's 2Q earnings report. Agilent reported an EPS of $0.44, $0.05 above consensus estimates. Management raised the mid-point of its FY16 EPS outlook by ~6c (to... More

Agilent (A): 'Drop the Mic Quarter' - Evercore ISI

Evercore ISI analyst, Ross Muken, sees value in Agilent (NYSE: A) in the high $40s / low $50s based on increased confidence in execution and likely upside to forecasts. The highlight in the quarter was an uptick to FCF while trends did not deteriorate on... More

Agilent (A) volatility elevated into Q2 EPS & revenue beat

Agilent (NYSE: A) is recently up $1.58 to $44.50 in the premarket after reporting Q2 EPS of 44c, compared to consensus 39c. May call option implied volatility is at 59, June is at 30; compared to its 52-week range of 28 to 43.

Straddle prices into quarter releases

Children's Place (NASDAQ: PLCE) May 67.5 straddle priced for 8.5% price movement into Q1

TJX (NYSE: TJX) May 75 straddle priced for 5.2% price movement into Q1

Momo (NASDAQ: MOMO) May 12.5 straddle... More

After-Hours Stock Movers 05/16: (GSAT) (CYH) (A) Higher; (AEGR) (RLYP) (P) Lower (more...)

Today's After-Hours Movers:

Aegerion Pharma (NASDAQ: AEGR) 13.4% LOWER; reported Q1 EPS of ($1.72), $1.14 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $35.7 million versus the consensus estimate of $43 million. Aegerion recorded $26.2 million in net product sales of JUXTAPID® (lomitapide) capsules in the first quarter of 2016, $23.6 million, or 90%, of which was from prescriptions written in the United... More

Agilent Technologies (A) Tops Q2 EPS by 5c; Guides FY16 EPS Above Views

Agilent Technologies (NYSE: A) reported Q2 EPS of $0.44, $0.05 better than the analyst estimate of $0.39. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $983.26 million.

GUIDANCE:

Agilent Technologies sees Q3 2016 EPS of $0.45-$0.47, versus the consensus of $0.47.... More

Agilent (A) May call volatility elevated into Q2

Agilent (NYSE: A) May call option implied volatility is at 57, June is at 29; compared to its 52-week range of 28 to 43 into the expected release of Q2 results today after the market close.

Trading Radar for 5/16: Agilent (A), AdCare (ADK), Cypress Energy (CELP), YOU On Demand (YOD) Report

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Earnings:

Alcobra Ltd. (Nasdaq: ADHD) - consensus loss $0.22
Celsion (Nasdaq: CLSN) - consensus loss $0.21
Cypress Energy Partners (NYSE: CELP) - consensus EPS $0.18
DHX Media (Nasdaq:... More

Agilent (A) May volatility increases as shares near two-year high into Q1

Agilent (NYSE: A) May call option implied volatility is at 46, June is at 29; compared to its 52-week range of 18 to 43 into the expected release of Q1 results on May 16.